<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37512587</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2218-1989</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Metabolites</Title><ISOAbbreviation>Metabolites</ISOAbbreviation></Journal><ArticleTitle>Integrated NMR and MS Analysis of the Plasma Metabolome Reveals Major Changes in One-Carbon, Lipid, and Amino Acid Metabolism in Severe and Fatal Cases of COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">879</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/metabo13070879</ELocationID><Abstract><AbstractText>Brazil has the second-highest COVID-19 death rate worldwide, and Rio de Janeiro is among the states with the highest rate in the country. Although vaccine coverage has been achieved, it is anticipated that COVID-19 will transition into an endemic disease. It is concerning that the molecular mechanisms underlying clinical evolution from mild to severe disease, as well as the mechanisms leading to long COVID-19, are not yet fully understood. NMR and MS-based metabolomics were used to identify metabolites associated with COVID-19 pathophysiology and disease outcome. Severe COVID-19 cases (n = 35) were enrolled in two reference centers in Rio de Janeiro within 72 h of ICU admission, alongside 12 non-infected control subjects. COVID-19 patients were grouped into survivors (n = 18) and non-survivors (n = 17). Choline-related metabolites, serine, glycine, and betaine, were reduced in severe COVID-19, indicating dysregulation in methyl donors. Non-survivors had higher levels of creatine/creatinine, 4-hydroxyproline, gluconic acid, and <i>N</i>-acetylserine, indicating liver and kidney dysfunction. Several changes were greater in women; thus, patients' sex should be considered in pandemic surveillance to achieve better disease stratification and improve outcomes. These metabolic alterations may be useful to monitor organ (dys) function and to understand the pathophysiology of acute and possibly post-acute COVID-19 syndromes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gama-Almeida</LastName><ForeName>Marcos C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-7995-447X</Identifier><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Gabriela D A</ForeName><Initials>GDA</Initials><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>L&#xed;via</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21041-361, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hottz</LastName><ForeName>Eugenio D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Laboratory of Immunothrombosis, Department of Biochemistry, Federal University of Juiz de Fora, Juiz de Fora 36936-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivens</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>LabMeta, Metabolomics Laboratory, Institute of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-598, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Hygor</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0005-1358-1689</Identifier><AffiliationInfo><Affiliation>LabMeta, Metabolomics Laboratory, Institute of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-598, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lipid Biochemistry and Lipidomics Laboratory, Department of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-598, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrett</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5823-311X</Identifier><AffiliationInfo><Affiliation>LabMeta, Metabolomics Laboratory, Institute of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-598, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Alexandre G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0002-7376-4939</Identifier><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lipid Biochemistry and Lipidomics Laboratory, Department of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-598, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carneiro</LastName><ForeName>Talita I A</ForeName><Initials>TIA</Initials><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbalho</LastName><ForeName>Bianca de O</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludwig</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8901-6970</Identifier><AffiliationInfo><Affiliation>Institute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2SQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struchiner</LastName><ForeName>Claudio J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0003-2114-847X</Identifier><AffiliationInfo><Affiliation>School of Applied Mathematics, Funda&#xe7;&#xe3;o Get&#xfa;lio Vargas, Rio de Janeiro 22231-080, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Social Medicine, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assun&#xe7;&#xe3;o-Miranda</LastName><ForeName>Iranaia</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5684-4788</Identifier><AffiliationInfo><Affiliation>LaRIV, Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>Ana Paula C</ForeName><Initials>APC</Initials><AffiliationInfo><Affiliation>National Center for Nuclear Magnetic Resonance-Jiri Jonas, Institute of Medical Biochemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozza</LastName><ForeName>Fernando A</ForeName><Initials>FA</Initials><Identifier Source="ORCID">0000-0003-4878-0256</Identifier><AffiliationInfo><Affiliation>National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D'Or Institute for Research and Education, Rio de Janeiro 22281-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozza</LastName><ForeName>Patr&#xed;cia T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21041-361, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Gilson C</ForeName><Initials>GC</Initials><Suffix>Jr</Suffix><Identifier Source="ORCID">0000-0002-2038-2267</Identifier><AffiliationInfo><Affiliation>LabMet-Laboratory of Metabolomics, Instituto de Biologia Roberto Alcantara Gomes (IBRAG), Department of Genetics, State University of Rio de Janeiro, Rio de Janeiro 20551-030, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Bacha</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0809-0218</Identifier><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lipid Biochemistry and Lipidomics Laboratory, Department of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-598, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>314971/2021-1</GrantID><Agency>National Council for Scientific and Technological Development</Agency><Country/></Grant><Grant><GrantID>260003/002690/2020</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro</Agency><Country/></Grant><Grant><GrantID>E-26/200.930/2022</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro</Agency><Country/></Grant><Grant><GrantID>E-26/201.259/2021</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro</Agency><Country/></Grant><Grant><GrantID>scholarship</GrantID><Agency>Coordena&#xe7;&#xe3;o de Aperfeicoamento de Pessoal de N&#xed;vel Superior</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Metabolites</MedlineTA><NlmUniqueID>101578790</NlmUniqueID><ISSNLinking>2218-1989</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">1H-NMR</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">fatal COVID-19</Keyword><Keyword MajorTopicYN="N">high-resolution mass spectrometry</Keyword><Keyword MajorTopicYN="N">metabolic alterations</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">sex differences</Keyword><Keyword MajorTopicYN="N">virus-host interactions</Keyword></KeywordList><CoiStatement>The authors declare no competing interest. The funders were not involved in the study design, collection, analysis, or interpretation of data, nor in the writing of the report or the decision to submit it for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37512587</ArticleId><ArticleId IdType="pmc">PMC10384698</ArticleId><ArticleId IdType="doi">10.3390/metabo13070879</ArticleId><ArticleId IdType="pii">metabo13070879</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cohen L.E., Spiro D.J., Viboud C. Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations. PLoS Pathog. 2022;18:e1010591. doi: 10.1371/journal.ppat.1010591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010591</ArticleId><ArticleId IdType="pmc">PMC9246171</ArticleId><ArticleId IdType="pubmed">35771775</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . COVID-19 Weekly Epidemiological Update World Health Organization. WHO; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Brasil. Secretarias Estaduais de Sa&#xfa;de. Painel Coronavirus.  [(accessed on 14 July 2023)];2023  Available online:  https://covid.saude.gov.br/2023.</Citation></Reference><Reference><Citation>Raoult D., Zumla A., Locatelli F., Ippolito G., Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020;4:66&#x2013;75. doi: 10.15698/cst2020.04.216.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2020.04.216</ArticleId><ArticleId IdType="pmc">PMC7064018</ArticleId><ArticleId IdType="pubmed">32292881</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N., Nie M., Pang H., Wang B., Hu J., Meng X., Li K., Ran X., Long Q., Deng H., et al. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 2021;12:1618. doi: 10.1038/s41467-021-21907-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21907-9</ArticleId><ArticleId IdType="pmc">PMC7955129</ArticleId><ArticleId IdType="pubmed">33712622</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19): Post COVID-19 Condition. 2021.  [(accessed on 14 July 2023)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Cancela-Cilleruelo I., Guerrero-Peral A., Mart&#xed;n-Guerrero J.D., Garc&#xed;a-Azor&#xed;n D., Cornejo-Mazzuchelli A., Hern&#xe1;ndez-Barrera V., Pellicer-Valero O.J. PPost-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients. JAMA Netw. Open. 2022;5:e2242106. doi: 10.1001/jamanetworkopen.2022.42106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.42106</ArticleId><ArticleId IdType="pmc">PMC9667330</ArticleId><ArticleId IdType="pubmed">36378309</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos G.C., Renovato-Martins M., de Brito N.M. The remodel of the &#x201c;central dogma&#x201d;: A metabolomics interaction perspective. Metabolomics. 2021;17:48. doi: 10.1007/s11306-021-01800-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-021-01800-8</ArticleId><ArticleId IdType="pmc">PMC8106972</ArticleId><ArticleId IdType="pubmed">33969452</ArticleId></ArticleIdList></Reference><Reference><Citation>Byers N.M., Fleshman A.C., Perera R., Molins C.R. Metabolomic insights into human arboviral infections: Dengue, chikungunya, and zika viruses. Viruses. 2019;11:225. doi: 10.3390/v11030225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11030225</ArticleId><ArticleId IdType="pmc">PMC6466193</ArticleId><ArticleId IdType="pubmed">30845653</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Bacha T., Struchiner C.J., Cordeiro M.T., Almeida F.C.L., Marques E.T., Da Poian A.T. 1H Nuclear Magnetic Resonance Metabolomics of Plasma Unveils Liver Dysfunction in Dengue Patients. J. Virol. 2016;90:7429&#x2013;7443. doi: 10.1128/JVI.00187-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00187-16</ArticleId><ArticleId IdType="pmc">PMC4984634</ArticleId><ArticleId IdType="pubmed">27279613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Zhou L., Sun X., Yan Z., Hu C., Wu J., Xu L., Li X., Liu H., Yin P., et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci. Rep. 2017;7:9110. doi: 10.1038/s41598-017-09536-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09536-z</ArticleId><ArticleId IdType="pmc">PMC5567209</ArticleId><ArticleId IdType="pubmed">28831119</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo C., Delafiori J., de Oliveira D.N., Guerreiro T.M., Esteves C.Z., Lima E.d.O., Pando-Robles V., Catharino R.R., Network T.Z.-U., Milanez G.P., et al. Serum metabolic alterations upon ZIKA infection. Front. Microbiol. 2017;8:1954. doi: 10.3389/fmicb.2017.01954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01954</ArticleId><ArticleId IdType="pmc">PMC5641361</ArticleId><ArticleId IdType="pubmed">29067015</ArticleId></ArticleIdList></Reference><Reference><Citation>Diop F., Vial T., Ferraris P., Wichit S., Bengue M., Hamel R., Talignani L., Liegeois F., Pompon J., Yssel H., et al. Zika virus infection modulates the metabolomic profile of microglial cells. PLoS ONE. 2018;13:e0206093. doi: 10.1371/journal.pone.0206093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206093</ArticleId><ArticleId IdType="pmc">PMC6201926</ArticleId><ArticleId IdType="pubmed">30359409</ArticleId></ArticleIdList></Reference><Reference><Citation>Girdhar K., Powis A., Raisingani A., Chrudinov&#xe1; M., Huang R., Tran T., Sevgi K., Dogru Y.D., Altindis E. Viruses and Metabolism: The Effects of Viral Infections and Viral Insulins on Host Metabolism. Annu. Rev. Virol. 2021;8:373&#x2013;391. doi: 10.1146/annurev-virology-091919-102416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-091919-102416</ArticleId><ArticleId IdType="pmc">PMC9175272</ArticleId><ArticleId IdType="pubmed">34586876</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Bacha T., Da Poian A.T. Virus-induced changes in mitochondrial bioenergetics as potential targets for therapy. Int. J. Biochem. Cell Biol. 2013;45:41&#x2013;46. doi: 10.1016/j.biocel.2012.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2012.09.021</ArticleId><ArticleId IdType="pubmed">23036789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S., de Jong A.W.M., Koning R.I., Agard D.A., Gr&#xfc;newald K., Koster A.J., et al. A molecular pore spans the double membrane of the coronavirus replication organelle. Science. 2020;369:1395&#x2013;1398. doi: 10.1126/science.abd3629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3629</ArticleId><ArticleId IdType="pmc">PMC7665310</ArticleId><ArticleId IdType="pubmed">32763915</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias S.S.G., Soares V.C., Ferreira A.C., Sacramento C.Q., Fintelman-Rodrigues N., Temerozo J.R., Teixeira L., da Silva M.A.N., Barreto E., Mattos M., et al. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020;16:e1009127. doi: 10.1371/journal.ppat.1009127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009127</ArticleId><ArticleId IdType="pmc">PMC7773323</ArticleId><ArticleId IdType="pubmed">33326472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M., Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G., et al. The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle. Nature. 2022;606:761&#x2013;768. doi: 10.1038/s41586-022-04835-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04835-6</ArticleId><ArticleId IdType="pmc">PMC7612910</ArticleId><ArticleId IdType="pubmed">35551511</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., Quan S., Zhang F., Sun R., Qian L., et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59&#x2013;72.e15. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ssler T., Berezhnoy G., Singh Y., Cannet C., Reinsperger T., Sch&#xe4;fer H., Spraul M., Kneilling M., Merle U., Trautwein C. Quantitative Serum NMR Spectroscopy Stratifies COVID-19 Patients and Sheds Light on Interfaces of Host Metabolism and the Immune Response with Cytokines and Clinical Parameters. Metabolites. 2022;12:1277. doi: 10.3390/metabo12121277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12121277</ArticleId><ArticleId IdType="pmc">PMC9781847</ArticleId><ArticleId IdType="pubmed">36557315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambikan A.T., Yang H., Krishnan S., Akusj&#xe4;rvi S.S., Gupta S., Lourda M., Sperk M., Arif M., Zhang C., Nordqvist H., et al. Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity. Cell Syst. 2022;13:665&#x2013;681.e4. doi: 10.1016/j.cels.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2022.06.006</ArticleId><ArticleId IdType="pmc">PMC9263811</ArticleId><ArticleId IdType="pubmed">35933992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionetto L., Ulivieri M., Capi M., De Bernardini D., Fazio F., Petrucca A., Pomes L.M., De Luca O., Gentile G., Casolla B., et al. Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study. Biochim. Biophys. Acta Mol. Basis Dis. 2021;1867:166042. doi: 10.1016/j.bbadis.2020.166042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2020.166042</ArticleId><ArticleId IdType="pmc">PMC7834629</ArticleId><ArticleId IdType="pubmed">33338598</ArticleId></ArticleIdList></Reference><Reference><Citation>Occelli C., Guigonis J.M., Lindenthal S., Cagnard A., Graslin F., Brglez V., Seitz-Polski B., Dellamonica J., Levraut J., Pourcher T. Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease. Front. Med. 2022;29:995069. doi: 10.3389/fmed.2022.995069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.995069</ArticleId><ArticleId IdType="pmc">PMC9556858</ArticleId><ArticleId IdType="pubmed">36250098</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera Oostdam A.S., Casta&#xf1;eda-Delgado J.E., Oropeza-Valdez J.J., Borrego J.C., Mon&#xe1;rrez-Espino J., Zheng J., Mandal R., Zhang L., Soto-Guzm&#xe1;n E., Fern&#xe1;ndez-Ruiz J.C. Immunometabolic signatures predict risk of progression to sepsis in COVID-19. PLoS ONE. 2021;16:e0256784. doi: 10.1371/journal.pone.0256784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256784</ArticleId><ArticleId IdType="pmc">PMC8405033</ArticleId><ArticleId IdType="pubmed">34460840</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J.A., Nemkov T., Bertolone L., Francis R.O., Hudson K.E., Zimring J.C., Hansen K.C., Hod E.A., et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327. doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Guo R., Kim S.H., Shah H., Zhang S., Liang J.H., Fang Y., Gentili M., Leary C.N.O., Elledge S.J., et al. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat. Commun. 2021;12:1676. doi: 10.1038/s41467-021-21903-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21903-z</ArticleId><ArticleId IdType="pmc">PMC7960988</ArticleId><ArticleId IdType="pubmed">33723254</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazzo H., Cardoso S.W., Ribeiro M.P.D., Moreira R., Coelho L.E., Jalil E.M., Japiass&#xfa; A.M., Gouv&#xea;a E.P., Nunes E.P., Andrade H.B. In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil. Lancet Reg. Health Am. 2022;11:100244. doi: 10.1016/j.lana.2022.100244. Erratum in Lancet Reg. Health Am. 2022, 11, 100300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100244</ArticleId><ArticleId IdType="pmc">PMC9001143</ArticleId><ArticleId IdType="pubmed">35434696</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues R.S., Motta Ribeiro G., Barreto M.M., Zin W.A., de Toledo-Mendes J., Martins P.A.G., de Almeida S.A., Bas&#xed;lio R., Martins-Gon&#xe7;alves R., Hottz E.D., et al. Increased Lung Immune Metabolic Activity in COVID-19 Survivors. Clin. Nucl. Med. 2022;47:1019&#x2013;1025. doi: 10.1097/RLU.0000000000004376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000004376</ArticleId><ArticleId IdType="pmc">PMC9653065</ArticleId><ArticleId IdType="pubmed">36026599</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R., Campos M.M., Palhinha L., Azevedo-Quintanilha I.G., Abud Mendes M., Ramos Temerozo J., Toledo-Mendes J., Rosado-de-Castro P.H., Bozza F.A., Souza Rodrigues R., et al. Persisting Platelet Activation and Hyperactivity in COVID-19 Survivors. Circ. Res. 2022;131:944&#x2013;947. doi: 10.1161/CIRCRESAHA.122.321659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321659</ArticleId><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133. doi: 10.1038/s41579-022-00846-2. Erratum in Nat. Rev. Microbiol. 2023, 21, 408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Temerozo J.R., Fintelman-Rodrigues N., Dos Santos M.C., Hottz E.D., Sacramento C.Q., de Paula Dias da Silva A., Mandacaru S.C., Dos Santos Moraes E.C., Trugilho M.R.O., Gesto J.S.M., et al. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome. 2022;10:65. doi: 10.1186/s40168-022-01260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01260-9</ArticleId><ArticleId IdType="pmc">PMC9024070</ArticleId><ArticleId IdType="pubmed">35459226</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 2020;20:e192&#x2013;e197. doi: 10.1016/S1473-3099(20)30483-7. Erratum in Lancet Infect Dis. 2020, 20, e250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang T.L., Shaka A.J. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reason. 1995;112:275&#x2013;279. doi: 10.1006/jmra.1995.1047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmra.1995.1047</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr H.Y., Purcell E.M. Effects of Diffusion on Free Precession in Nuclear Magnetic Resonance Experiments. Phys. Rev. 1954;94:630&#x2013;638. doi: 10.1103/PhysRev.94.630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRev.94.630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig C., G&#xfc;nther U.L. MetaboLab&#x2014;Advanced NMR data processing and analysis for metabolomics. BMC Bioinform. 2011;12:366. doi: 10.1186/1471-2105-12-366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-366</ArticleId><ArticleId IdType="pmc">PMC3179975</ArticleId><ArticleId IdType="pubmed">21914187</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons H.M., Ludwig C., G&#xfc;nther U.L., Viant M.R. Improved classification accuracy in 1- and 2-dimensional NMR metabolomics data using the variance stabilising generalised logarithm transformation. BMC Bioinform. 2007;8:234. doi: 10.1186/1471-2105-8-234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-8-234</ArticleId><ArticleId IdType="pmc">PMC1965488</ArticleId><ArticleId IdType="pubmed">17605789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bingol K., Li D.-W., Bruschweiler-Li L., Cabrera O.A., Megraw T., Zhang F., Br&#xfc;schweiler R. Unified and Isomer-Specific NMR Metabolomics Database for the Accurate Analysis of 13 C&#x2013; 1 H HSQC Spectra. ACS Chem. Biol. 2015;10:452&#x2013;459. doi: 10.1021/cb5006382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb5006382</ArticleId><ArticleId IdType="pmc">PMC4340359</ArticleId><ArticleId IdType="pubmed">25333826</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinette S.L., Zhang F., Br&#xfc;schweiler-Li L., Br&#xfc;schweiler R. Web Server Based Complex Mixture Analysis by NMR. Anal. Chem. 2008;80:3606&#x2013;3611. doi: 10.1021/ac702530t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac702530t</ArticleId><ArticleId IdType="pubmed">18422338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich E.L., Akutsu H., Doreleijers J.F., Harano Y., Ioannidis Y.E., Lin J., Livny M., Mading S., Maziuk D., Miller Z., et al. BioMagResBank. Nucleic Acids Res. 2007;36:D402&#x2013;D408. doi: 10.1093/nar/gkm957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm957</ArticleId><ArticleId IdType="pmc">PMC2238925</ArticleId><ArticleId IdType="pubmed">17984079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart D.S., Feunang Y.D., Marcu A., Guo A.C., Liang K., V&#xe1;zquez-Fresno R., Sajed T., Johnson D., Li C., Karu N., et al. HMDB 4.0: The human metabolome database for 2018. Nucleic Acids Res. 2018;46:D608&#x2013;D617. doi: 10.1093/nar/gkx1089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1089</ArticleId><ArticleId IdType="pmc">PMC5753273</ArticleId><ArticleId IdType="pubmed">29140435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan J.A., Gika H., Beger R.D., Bearden D., Dunn W.B., Goodacre R., Theodoridis G., Witting M., Yu L.R., Wilson I.D., et al. Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management. Metabolomics. 2022;18:70. doi: 10.1007/s11306-022-01926-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-022-01926-3</ArticleId><ArticleId IdType="pmc">PMC9420093</ArticleId><ArticleId IdType="pubmed">36029375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsugawa H., Cajka T., Kind T., Ma Y., Higgins B., Ikeda K., Kanazawa M., VanderGheynst J., Fiehn O., Arita M. MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat. Methods. 2015;12:523&#x2013;526. doi: 10.1038/nmeth.3393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3393</ArticleId><ArticleId IdType="pmc">PMC4449330</ArticleId><ArticleId IdType="pubmed">25938372</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., Brown M., Knowles J.D., Halsall A., Haselden J.N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 2011;6:1060&#x2013;1083. doi: 10.1038/nprot.2011.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.335</ArticleId><ArticleId IdType="pubmed">21720319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsugawa H., Kind T., Nakabayashi R., Yukihira D., Tanaka W., Cajka T., Saito K., Fiehn O., Arita M. Hydrogen Rearrangement Rules: Computational MS/MS Fragmentation and Structure Elucidation Using MS-FINDER Software. Anal. Chem. 2016;88:7946&#x2013;7958. doi: 10.1021/acs.analchem.6b00770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.6b00770</ArticleId><ArticleId IdType="pmc">PMC7063832</ArticleId><ArticleId IdType="pubmed">27419259</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadhurst D., Goodacre R., Reinke S.N., Kuligowski J., Wilson I.D., Lewis M.R., Dunn W.B. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018;14:72. doi: 10.1007/s11306-018-1367-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-018-1367-3</ArticleId><ArticleId IdType="pmc">PMC5960010</ArticleId><ArticleId IdType="pubmed">29805336</ArticleId></ArticleIdList></Reference><Reference><Citation>McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983;29:538&#x2013;542. doi: 10.1093/clinchem/29.3.538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/29.3.538</ArticleId><ArticleId IdType="pubmed">6825269</ArticleId></ArticleIdList></Reference><Reference><Citation>Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin. Chem. 1983;19:1350&#x2013;1356. doi: 10.1093/clinchem/19.12.1350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/19.12.1350</ArticleId><ArticleId IdType="pubmed">4757363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong J., Wishart D.S., Xia J. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis. Cur. Protoc. Bioinform. 2019;68:e86. doi: 10.1002/cpbi.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpbi.86</ArticleId><ArticleId IdType="pubmed">31756036</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L., Friedman J.H., Olshen R.A., Stone C.J. Classification and Regression Trees. Routledge; New York, NY, USA: 2017. 368p</Citation></Reference><Reference><Citation>Therneau T., Atkinson B., Port B.R. rpart: Recursive Partitioning and Regression Trees 2022.  [(accessed on 10 July 2023)].  Available online:  https://github.com/bethatkinson/rpart.</Citation></Reference><Reference><Citation>Ament Z., Bevers M.B., Wolcott Z., Kimberly W.T., Acharjee A. Uric Acid and Gluconic Acid as Predictors of Hyperglycemia and Cytotoxic Injury after Stroke. Transl. Stroke Res. 2021;12:293&#x2013;302. doi: 10.1007/s12975-020-00862-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-020-00862-5</ArticleId><ArticleId IdType="pmc">PMC7933067</ArticleId><ArticleId IdType="pubmed">33067777</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Ning N., Li B., Luo D., Qin E., Yu W., Wang J., Yang G., Nan N., He Z., et al. Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates with Inflammation and Coagulation in COVID-19 Severe Patients. Front. Microbiol. 2021;12:723818. doi: 10.3389/fmicb.2021.723818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.723818</ArticleId><ArticleId IdType="pmc">PMC8678452</ArticleId><ArticleId IdType="pubmed">34925252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen D., Zheng Z., Surapaneni A., Yu B., Zhou L., Zhou W., Xie D., Shou H., Avila-Pacheco J., Kalim S., et al. Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study. JCI Insight. 2022;7:e161696. doi: 10.1172/jci.insight.161696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.161696</ArticleId><ArticleId IdType="pmc">PMC9714776</ArticleId><ArticleId IdType="pubmed">36048534</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia B.S.B., Ferreira V.G., Piagge P.M.F.D., Almeida M.B., Assun&#xe7;&#xe3;o N.A., Raimundo J.R.S., Fonseca F.L.A., Carrilho E., Cardoso D.R. 1H qNMR-Based Metabolomics Discrimination of COVID-19 Severity. J Proteome Res. 2022;21:1640&#x2013;1653. doi: 10.1021/acs.jproteome.1c00977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00977</ArticleId><ArticleId IdType="pubmed">35674498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazak L., Rahbani J.F., Samborska B., Lu G.Z., Jedrychowski M.P., Lajoie M., Zhang S., Ramsay L., Dou F.Y., Tenen D., et al. Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity. Nat. Metab. 2019;1:360&#x2013;370. doi: 10.1038/s42255-019-0035-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-019-0035-x</ArticleId><ArticleId IdType="pmc">PMC6544051</ArticleId><ArticleId IdType="pubmed">31161155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazak L., Cohen P. Creatine metabolism: Energy homeostasis, immunity and cancer biology. Nat. Rev. Endocrinol. 2020;16:421&#x2013;436. doi: 10.1038/s41574-020-0365-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-0365-5</ArticleId><ArticleId IdType="pubmed">32493980</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S., He W., Wu G. Hydroxyproline in animal metabolism, nutrition, and cell signalling. Amino Acids. 2022;54:513&#x2013;528. doi: 10.1007/s00726-021-03056-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-021-03056-x</ArticleId><ArticleId IdType="pubmed">34342708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducker G.S., Rabinowitz J.D. One-Carbon Metabolism in Health and Disease. Cell Metab. 2017;25:27&#x2013;42. doi: 10.1016/j.cmet.2016.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.08.009</ArticleId><ArticleId IdType="pmc">PMC5353360</ArticleId><ArticleId IdType="pubmed">27641100</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Veen J.N., Kennelly J.P., Wan S., Vance J.E., Vance D.E., Jacobs R.L. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta Biomembr. 2017;1859:1558&#x2013;1572. doi: 10.1016/j.bbamem.2017.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2017.04.006</ArticleId><ArticleId IdType="pubmed">28411170</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva R.P., Eudy B.J., Deminice R. One-Carbon Metabolism in Fatty Liver Disease and Fibrosis: One-Carbon to Rule Them All. J. Nutr. 2020;150:994&#x2013;1003. doi: 10.1093/jn/nxaa032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxaa032</ArticleId><ArticleId IdType="pubmed">32119738</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira L., Temerozo J.R., Pereira-Dutra F.S., Ferreira A.C., Mattos M., Gon&#xe7;alves B.S., Sacramento C.Q., Palhinha L., Cunha-Fernandes T., Dias S.S.G., et al. Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts. Front. Immunol. 2022;13:820131. doi: 10.3389/fimmu.2022.820131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.820131</ArticleId><ArticleId IdType="pmc">PMC8895251</ArticleId><ArticleId IdType="pubmed">35251001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge S., Nitschke P., Kimhofer T., Coudert J.D., Begum S., Bong S.H., Sacramento C.Q., Palhinha L., Cunha-Fernandes T., Dias S.S., et al. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines. J. Proteome Res. 2021;20:1382&#x2013;1396. doi: 10.1021/acs.jproteome.0c00876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00876</ArticleId><ArticleId IdType="pubmed">33426894</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Wu D., Shu T., Yang X., Song J.-X., Zhang M., Yao C., Liu W., Huang M., Yu Y., Yang Q., et al. Plasma metabolomic and lipidomic alterations associated with COVID-19. Natl. Sci. Rev. 2020;7:1157&#x2013;1168. doi: 10.1093/nsr/nwaa086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa086</ArticleId><ArticleId IdType="pmc">PMC7197563</ArticleId><ArticleId IdType="pubmed">34676128</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A.B., Gu X., Buffa J.A., Hurd A.G., Wang Z., Zhu W., Gupta N., Skye S.M., Cody D.B., Levison B.S., et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat. Med. 2018;24:1407&#x2013;1417. doi: 10.1038/s41591-018-0128-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0128-1</ArticleId><ArticleId IdType="pmc">PMC6129214</ArticleId><ArticleId IdType="pubmed">30082863</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Li X., Yang F., Zhao R., Pan X., Liang J., Tian L., Li X., Liu L., Xing Y., et al. Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target. Front. Pharmacol. 2019;10:1360. doi: 10.3389/fphar.2019.01360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01360</ArticleId><ArticleId IdType="pmc">PMC6877687</ArticleId><ArticleId IdType="pubmed">31803054</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolis A.S., Manolis T.A., Manolis A.A., Papatheou D., Melita H. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management. J. Cardiovasc. Pharmacol. Ther. 2021;26:12&#x2013;24. doi: 10.1177/1074248420958973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248420958973</ArticleId><ArticleId IdType="pmc">PMC7492826</ArticleId><ArticleId IdType="pubmed">32924567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett J.A., Mastrangelo M.A., Ture S.K., Smith C.O., Loelius S.G., Berg R.A., Shi X., Burke R.M., Spinelli S.L., Cameron S.J., et al. The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function. Nat. Commun. 2020;11:3479. doi: 10.1038/s41467-020-17254-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17254-w</ArticleId><ArticleId IdType="pmc">PMC7359028</ArticleId><ArticleId IdType="pubmed">32661250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibal L., Agarwal S.C., Home P.D., Boger R.H. The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr. Cardiol. Rev. 2010;6:82&#x2013;90. doi: 10.2174/157340310791162659.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157340310791162659</ArticleId><ArticleId IdType="pmc">PMC2892080</ArticleId><ArticleId IdType="pubmed">21532773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W.C., Li G., Huang C.Y., Jiang J.L. Asymmetric dimethylarginine: An crucial regulator in tissue fibrosis. Eur. J. Pharmacol. 2019;854:54&#x2013;61. doi: 10.1016/j.ejphar.2019.03.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.03.055</ArticleId><ArticleId IdType="pubmed">30951718</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren W., Rajendran R., Zhao Y., Tan B., Wu G., Bazer F.W., Zhu G., Peng Y., Huang X., Deng J., et al. Amino Acids as Mediators of Metabolic Cross Talk between Host and Pathogen. Front. Immunol. 2018;9:319. doi: 10.3389/fimmu.2018.00319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00319</ArticleId><ArticleId IdType="pmc">PMC5835074</ArticleId><ArticleId IdType="pubmed">29535717</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Yin Y.L., Li D., Kim S.W., Wu G. Amino acids and immune function. Br. J. Nutr. 2007;98:237&#x2013;252. doi: 10.1017/S000711450769936X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S000711450769936X</ArticleId><ArticleId IdType="pubmed">17403271</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele I., Fleming R.M.T. Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication. Comput. Struct. Biotechnol. J. 2022;20:4098&#x2013;4109. doi: 10.1016/j.csbj.2022.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2022.07.019</ArticleId><ArticleId IdType="pmc">PMC9296228</ArticleId><ArticleId IdType="pubmed">35874091</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira L.G., de Souza Y.A., Yamamoto P., Carregari V.C., Crunfli F., Reis-de-Oliveira G., Costa L., Vendramini P.H., Duque E.A., Dos Santos N.B., et al. SARS-CoV-2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes. J. Neurochem. 2022;163:113&#x2013;132. doi: 10.1111/jnc.15679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15679</ArticleId><ArticleId IdType="pmc">PMC9350388</ArticleId><ArticleId IdType="pubmed">35880385</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva F.T.K., Freitas-Fernandes L.B., Marques B.B.F., de Ara&#xfa;jo C.S., da Silva B.J., Guimar&#xe3;es T.C., Fischer R.G., Tinoco E.M.B., Valente A.P. Salivary Metabolomic Analysis Reveals Amino Acid Metabolism Shift in SARS-CoV-2 Virus Activity and Post-Infection Condition. Metabolites. 2023;13:263. doi: 10.3390/metabo13020263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13020263</ArticleId><ArticleId IdType="pmc">PMC9962089</ArticleId><ArticleId IdType="pubmed">36837882</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;ez-Franco J.C., Maravillas-Montero J.L., Mej&#xed;a-Dom&#xed;nguez N.R., Torres-Ruiz J., Tamez-Torres K.M., P&#xe9;rez-Fragoso A. Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology. PLoS ONE. 2022;17:e0274910. doi: 10.1371/journal.pone.0274910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274910</ArticleId><ArticleId IdType="pmc">PMC9488784</ArticleId><ArticleId IdType="pubmed">36126080</ArticleId></ArticleIdList></Reference><Reference><Citation>Frampas C.F., Longman K., Spick M., Lewis H.M., Costa C.D.S., Stewart A., Baig M.H., Sudhakar D.R., Kalaiarasan P., Subbarao N., et al. Untargeted saliva metabolomics by liquid chromatography-Mass spectrometry reveals markers of COVID-19 severity. PLoS ONE. 2022;17:e0274967. doi: 10.1371/journal.pone.0274967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274967</ArticleId><ArticleId IdType="pmc">PMC9498978</ArticleId><ArticleId IdType="pubmed">36137157</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltais-Payette I., Lajeunesse-Trempe F., Pibarot P., Biertho L., Tchernof A. Association between Circulating Amino Acids and COVID-19 Severity. Metabolites. 2023;13:201. doi: 10.3390/metabo13020201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13020201</ArticleId><ArticleId IdType="pmc">PMC9959167</ArticleId><ArticleId IdType="pubmed">36837819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell J.D., Brown J.C., Nicholson J.K., Sadler P.J. Assignment of resonances for &#x201c;acute-phase&#x201d; glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett. 1987;215:311&#x2013;315. doi: 10.1016/0014-5793(87)80168-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(87)80168-0</ArticleId><ArticleId IdType="pubmed">2438159</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E., Nicholson J.K., Lodge S., Nitschke P., Kimhofer T., Wist J. Diffusion and relaxation edited proton NMR spectroscopy of plasma reveals a high-fidelity supramolecular biomarker signature of SARS-CoV-2 infection. Anal. Chem. 2021;93:3976&#x2013;3986. doi: 10.1021/acs.analchem.0c04952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c04952</ArticleId><ArticleId IdType="pubmed">33577736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipman D., Safo S.E., Chekouo T. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity. PLoS ONE. 2022;17:e0267047. doi: 10.1371/journal.pone.0267047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267047</ArticleId><ArticleId IdType="pmc">PMC9038205</ArticleId><ArticleId IdType="pubmed">35468151</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu S., Liu H., Li W., Lin F., Jiang L., Li X., Xu P., Zhang L., Zhao L., et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J. Hepatol. 2020;73:807&#x2013;816. doi: 10.1016/j.jhep.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7211738</ArticleId><ArticleId IdType="pubmed">32437830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagana S.M., Kudose S., Iuga A.C., Lee M.J., Fazlollahi L., Remotti H.E., Del Portillo A., De Michele S., de Gonzalez A.K., Saqi A., et al. Hepatic pathology in patients dying of COVID-19: A series of 40 cases including clinical, histologic, and virologic data. Mod. Pathol. 2020;33:2147&#x2013;2155. doi: 10.1038/s41379-020-00649-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-00649-x</ArticleId><ArticleId IdType="pmc">PMC7424245</ArticleId><ArticleId IdType="pubmed">32792598</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I., Muelas M.W., Taylor J.M., Davison A.S., Xu Y., Grixti J.M., Gotts N., Sorokin A., Goodacre R., Kell D.B. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics. 2021;18:6. doi: 10.1007/s11306-021-01859-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-021-01859-3</ArticleId><ArticleId IdType="pmc">PMC8686810</ArticleId><ArticleId IdType="pubmed">34928464</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez-Medina M.U., Cerda-Reyes E., Galeana-Pav&#xf3;n A., L&#xf3;pez-Luna C.E., Ram&#xed;rez-Portillo P.M., Iba&#xf1;ez-Cervantes G., Torres-V&#xe1;zquez J., Vargas-De-Le&#xf3;n C. Interaction of metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019. Hepatol. Commun. 2022;6:2000&#x2013;2010. doi: 10.1002/hep4.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep4.1957</ArticleId><ArticleId IdType="pmc">PMC9110946</ArticleId><ArticleId IdType="pubmed">35438253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooli R.G.R., Ramakrishnan S.K. Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease. Front. Physiol. 2022;13:946474. doi: 10.3389/fphys.2022.946474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.946474</ArticleId><ArticleId IdType="pmc">PMC9289363</ArticleId><ArticleId IdType="pubmed">35860662</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosolanka R., Liptak P., Baranovicova E., Bobcakova A., Vysehradsky R., Duricek M., Kapinova A., Dvorska D., Dankova Z., Simekova K., et al. Changes in the Urine Metabolomic Profile in Patients Recovering from Severe COVID-19. Metabolites. 2023;13:364. doi: 10.3390/metabo13030364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13030364</ArticleId><ArticleId IdType="pmc">PMC10058594</ArticleId><ArticleId IdType="pubmed">36984804</ArticleId></ArticleIdList></Reference><Reference><Citation>De Souza Nogueira J., Santos-Rebou&#xe7;as C.B., Piergiorge R.M., Valente A.P., Gama-Almeida M.C., El-Bacha T., Lopes Moreira M.L., Baptista Marques B.S., de Siqueira J.R., de Carvalho E.M., et al. Metabolic Adaptations Correlated with Antibody Response after Immunization with Inactivated SARS-CoV-2 in Brazilian Subjects. J. Proteome Res. 2023;22:1908&#x2013;1922. doi: 10.1021/acs.jproteome.3c00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.3c00014</ArticleId><ArticleId IdType="pubmed">37167433</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur V.P., Nemkov T., de Boer E., Mohning M.P., Baraghoshi D., Cendali F.I., San-Mill&#xe1;n I., Petrache I., D&#x2019;Alessandro A. Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis H.-M., Liu Y., Frampas C.F., Longman K., Spick M., Stewart A., Sinclair E., Kasar N., Greener D., Whetton A.D., et al. Metabolomics Markers of COVID-19 Are Dependent on Collection Wave. Metabolites. 2022;12:713. doi: 10.3390/metabo12080713.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12080713</ArticleId><ArticleId IdType="pmc">PMC9415837</ArticleId><ArticleId IdType="pubmed">36005585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 2020;11:29. doi: 10.1186/s13293-020-00304-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00304-9</ArticleId><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Escarcega R.D., Honarpisheh P., Colpo G.D., Ahnstedt H.W., Couture L., Juneja S., Torres G., Ortiz G.J., Sollome J., Tabor N., et al. Sex differences in global metabolomic profiles of COVID-19 patients. Cell Death Dis. 2022;13:461. doi: 10.1038/s41419-022-04861-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04861-2</ArticleId><ArticleId IdType="pmc">PMC9106988</ArticleId><ArticleId IdType="pubmed">35568706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos F.C., Virseda-Berdices A., Resino S., Ryan P., Mart&#xed;nez-Gonz&#xe1;lez O., Per&#xe9;z-Garc&#xed;a F., Martin-Vicente M., Brochado-Kith O., Blancas R., Bartolome-S&#xe1;nchez S., et al. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation. Front. Immunol. 2022;13:925558. doi: 10.3389/fimmu.2022.925558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.925558</ArticleId><ArticleId IdType="pmc">PMC9280146</ArticleId><ArticleId IdType="pubmed">35844615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N., Barthel A., Schedl A., Herzig S., Varga Z., Gebhard C., Mayr M., Hantel C., Beuschlein F., Wolfrum C., et al. Sexual dimorphism in COVID-19: Potential clinical and public health implications. Lancet Diabetes Endocrinol. 2022;10:221&#x2013;230. doi: 10.1016/S2213-8587(21)00346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00346-6</ArticleId><ArticleId IdType="pmc">PMC8803381</ArticleId><ArticleId IdType="pubmed">35114136</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Redondo R., Conde R., Bizkarguenaga M., Bruzzone C., La&#xed;n A., Gonz&#xe1;lez-Valle B., Iriberri M., Ramos-Acosta C., Anguita E., Arriaga Lariz J.I., et al. An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study. Metabolites. 2022;12:1206. doi: 10.3390/metabo12121206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12121206</ArticleId><ArticleId IdType="pmc">PMC9788519</ArticleId><ArticleId IdType="pubmed">36557244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner L.W., Amberg A., Barrett D., Beale M.H., Beger R., Daykin C.A., Fan T.W.-M., Fiehn O., Goodacre R., Griffin J.L., et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI) Metabolomics. 2007;3:211&#x2013;221. doi: 10.1007/s11306-007-0082-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-007-0082-2</ArticleId><ArticleId IdType="pmc">PMC3772505</ArticleId><ArticleId IdType="pubmed">24039616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>